ID
45433
Descripción
Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Uterine Cervical Neoplasms,Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000628 In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect and analyze HPV infection in the same sample.
Link
Palabras clave
Versiones (1)
- 29/11/22 29/11/22 - Chiara Middel
Titular de derechos de autor
Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA
Subido en
29 de noviembre de 2022
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000628 Characterization of a Metastatic Cervical Cancer Using NGS
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
Similar models
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
C0242481 (UMLS CUI [1,2])
C0035168 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,3])
C1511726 (UMLS CUI [1,4])